Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia. - Wikidata - awgldk - TriplyDB

Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

http://www.wikidata.org/entity/Q37546815

about

Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.Prevalence and detection of mixed-population enterococcal bacteremia.

P2860

Q42154638-7237DDAB-EFEE-424B-AFCD-481A30C5D530 Q42735545-5FC42082-61CE-4D76-B857-C9CF8F2A4338

P2860

Frequency of susceptibility testing for patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.

http://www.wikidata.org/entity/Q37546815

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 October 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@en

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@nl

type

label

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@en

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@nl

prefLabel

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@en

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@nl

P1433

Q37546815-02F9BC96-497C-496F-B26C-F6949B1F7FDD

P1476

Q37546815-C1E92E21-5FD3-454E-9F78-FBE2C8E042B2

P2093

Q37546815-19E66B1F-4FF1-43FE-B396-AB6721CCD326

Q37546815-CCE6B8DA-9F05-4481-9630-F8FB8D5CA7B4

Q37546815-EF0640AB-B602-4410-B6F4-7194E2C79160

Q37546815-F099EA2C-1DB3-4651-97BE-BA19994D3BCD

P2860

Q37546815-04404FC5-BCFF-4DB8-AEEC-5EE39BCF4899

Q37546815-047871ED-8B3B-43FB-9207-CCA9E34BC6BD

Q37546815-0AEB1CF5-581A-459F-8A36-A8D26AB81D43

Q37546815-0B601312-8F1F-41EC-99B3-76DD506EA954

Q37546815-156BC3FB-4ACE-43C1-A4E4-89E58296717B

Q37546815-19B0CA85-6701-422B-8FF8-F8B85EACB0D3

Q37546815-1DF3062A-2384-4555-861B-D01DA69945B5

Q37546815-2959DA92-32A5-425E-937E-8F293A38EBC1

Q37546815-2B037C5A-7BFC-4B18-92D4-4227ADA7DB7A

Q37546815-31701448-5BF0-4526-9F59-9A36FD224E75

P304

Q37546815-24159646-BD03-4609-9624-464A7CDE3500

P31

Q37546815-37C667ED-A0A8-4C73-9C36-DA719CC836CC

Q37546815-90155cd5-268a-4956-bab3-7d264c6d9fca

P356

Q37546815-6A88D98C-B747-4AD3-BBA3-36ACFB928320

P407

Q37546815-DC221585-D0D0-49E0-A81D-A8B98BD0EE88

P433

Q37546815-DF2D9531-C358-4153-8240-2630BDD16F6D

P478

Q37546815-DC3FD27D-6FA2-4540-A326-CE2C695FCEA0

P50

Q37546815-06970446-C887-4181-9B17-DC33A7CF43FC

P577

Q37546815-2F5086C3-D47A-4C14-AED8-BEDFA0F5DE2E

P698

Q37546815-EEDB942A-D366-4B66-8FAE-16CCFAEEF1CA

P921

Q37546815-252D0CB8-4CE1-443B-9402-D6FFD47B045B

P932

Q37546815-66ADE760-C631-4CF9-862C-37AFAD206387

P356

P1433

Journal of Clinical Microbiology

P1476

Frequency of susceptibility te ...... phylococcus aureus bacteremia.

@en

P2093

April M Bobenchik

http://www.w3.org/2001/XMLSchema#string

Carmen L Giltner

http://www.w3.org/2001/XMLSchema#string

Janet A Hindler

http://www.w3.org/2001/XMLSchema#string

Romney M Humphries

http://www.w3.org/2001/XMLSchema#string

P2860

Linezolid resistance in Staphylococcus aureus: gene dosage effect, stability, fitness costs, and cross-resistances

Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus

Single-dose daptomycin pharmacokinetics in chronic haemodialysis patients.

Comparison of ATB staph, rapid ATB staph, Vitek, and E-test methods for detection of oxacillin heteroresistance in staphylococci possessing mecA

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin.

Population pharmacokinetics of daptomycin

Susceptibility relationship between vancomycin and daptomycin in Staphylococcus aureus: facts and assumptions.

P304

357-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.02081-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Theodoros Kelesidis

P577

2013-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24153125

http://www.w3.org/2001/XMLSchema#string

P921

methicillin-resistant Staphylococcus aureus

P932

3911476

http://www.w3.org/2001/XMLSchema#string